Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NCT02080650 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Renal Cell Carcinoma
Bladder Cancer
Colorectal Cancer
Gastric Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Advanced MET Amplified Solid Tumor

Interventions

DEVICE: Mesenchymal-marker based ferrofluid (c-MET)
DEVICE: Epithelial cell adhesion molecule (EpCAM) ferrofluid

Sponsor

Duke University

Collaborators

[object Object]
[object Object]